Compound ID | 169
Class: Peptide-locked nucleic acid
Spectrum of activity: | Gram-positive |
Details of activity: | MRSA (methicillin resistant Staphylococcus aureus) |
Institute where first reported: | Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China |
Year first mentioned: | 2015 |
Highest developmental phase: | Preclinical |
Development status: | Active |
External links: | |
Citations: |
|